Study findings indicate that droplet digital polymerase chain reaction (ddPCR) may be more accurate than real-time quantitative PCR in measuring minimal residual disease (MRD) among pediatric patients ...
Standardization is needed in CAR-T cell therapy development due to its inherent complexity. Chimeric antigen receptor (CAR)-T cells have already changed how certain cancers are treated. As of February ...
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study Plasma cfDNA and pathology specimens of 36 patients were analyzed. Agreement ...
In recent years, liquid biopsy approaches have emerged as powerful tools in oncology, enabling non‑invasive, real‑time insights into tumor dynamics. Among these technologies, droplet digital PCR ...
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer We developed a ddPCR assay to sensitively detect tumor-derived hypermethylated RASSF1A ...
Droplet digital polymerase chain reaction (ddPCR) technology is emerging as an efficient, accurate, and precise way to measure transgene copy numbers. With it, scientists may screen for clonal ...
Adeno-associated viruses (AAV) are powerful instruments in gene therapy. AAV particles comprise a protein capsid that along with the desired genome, containing both is considered a full capsid.
Chimeric antigen receptor (CAR) T cells culminate from multiple significant advances in science, from tumor sequencing to genetic engineering and immunotherapy. Unsurprisingly, CAR T-cell therapy was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results